We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
(+20%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$613M |
| 2 |
Match Group
MTCH
|
+$518M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
RTX Corp
RTX
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$828M |
| 2 |
Microsoft
MSFT
|
+$510M |
| 3 |
Gilead Sciences
GILD
|
+$465M |
| 4 |
Merck
MRK
|
+$376M |
| 5 |
Walmart Inc
WMT
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Washington Trust Bancorp
WASH
$741M
| $3.58M | ﹤0.01% |
109,431
+43,877
| +67% | +$1.43M |
|
|
XRN
2077
Chiron Real Estate Inc
XRN
$477M
| $3.57M | ﹤0.01% |
62,985
-3,221
| -5% | -$175K |
|
2078
Liberty Global Class C
LBTYK
$3.49B
| $3.57M | ﹤0.01% |
165,772
+86,707
| +110% | +$1.73M |
|
2079
Cue Biopharma
CUE
$114M
| $3.55M | ﹤0.01% |
4,828
+1,943
| +67% | +$1.41M |
|
|
LGF.B
2080
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $3.52M | ﹤0.01% |
515,606
-377,860
| -42% | -$2.61M |
|
|
WOW
2081
DELISTED
WideOpenWest
WOW
| $3.51M | ﹤0.01% |
665,689
+59,973
| +10% | +$338K |
|
2082
Alaunos Therapeutics
TCRT
$4.86M
| $3.5M | ﹤0.01% |
7,123
+1,717
| +32% | +$766K |
|
|
CCXI
2083
DELISTED
ChemoCentryx, Inc.
CCXI
| $3.5M | ﹤0.01% |
434,381
-15,006
| -3% | -$817K |
|
|
THR
2084
DELISTED
Thermon Group Holdings
THR
| $3.49M | ﹤0.01% |
239,359
-84,235
| -26% | -$1.25M |
|
2085
Adtran
ADTN
$616M
| $3.47M | ﹤0.01% |
317,850
-67,463
| -18% | -$697K |
|
2086
Minerva Neurosciences
NERV
$199M
| $3.47M | ﹤0.01% |
32,207
-18,346
| -36% | -$1.08M |
|
|
EVRI
2087
DELISTED
Everi Holdings
EVRI
| $3.46M | ﹤0.01% |
671,221
-153,088
| -19% | -$778K |
|
2088
Neurogene
NGNE
$712M
| $3.46M | ﹤0.01% |
+10,415
| New | +$2.71M |
|
|
CIR
2089
DELISTED
CIRCOR International, Inc
CIR
| $3.46M | ﹤0.01% |
135,708
+57,210
| +73% | +$891K |
|
|
HUD
2090
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $3.46M | ﹤0.01% |
709,490
+327,692
| +86% | +$1.71M |
|
2091
Vishay Precision Group
VPG
$914M
| $3.45M | ﹤0.01% |
140,404
+32,590
| +30% | +$733K |
|
2092
Matthews International
MATW
$739M
| $3.44M | ﹤0.01% |
180,221
+41,676
| +30% | +$888K |
|
2093
Quince Therapeutics
QNCX
$29.5M
| $3.44M | ﹤0.01% |
372
+145
| +64% | +$1.33M |
|
2094
Photronics
PLAB
$1.93B
| $3.44M | ﹤0.01% |
309,095
-239,700
| -44% | -$2.75M |
|
|
NP
2095
DELISTED
Neenah, Inc. Common Stock
NP
| $3.44M | ﹤0.01% |
69,513
-1,330
| -2% | -$63.9K |
|
2096
nLIGHT
LASR
$3.17B
| $3.44M | ﹤0.01% |
154,315
+37,379
| +32% | +$708K |
|
|
ENDP
2097
DELISTED
Endo International plc
ENDP
| $3.42M | ﹤0.01% |
998,222
-162,185
| -14% | -$621K |
|
|
GTS
2098
DELISTED
Triple-S Management Corporation
GTS
| $3.41M | ﹤0.01% |
179,109
-141,477
| -44% | -$2.43M |
|
2099
Mesa Laboratories
MLAB
$574M
| $3.39M | ﹤0.01% |
15,655
+360
| +2% | +$83K |
|
|
CNCE
2100
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $3.38M | ﹤0.01% |
339,749
-43,286
| -11% | -$415K |
|
Similar funds
VFT
Nuveen's Q2 2020 Portfolio in Review
As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
- Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
- Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
- Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
- Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
- Nuveen opened 266 new positions and closed 200 in Q2 2020.
- Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.
Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.